BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8225473)

  • 21. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separation of 32P-labelled nucleoside 3',5'-bisphosphate adducts by HPLC.
    Pfau W; Lecoq S; Hughes NC; Seidel A; Platt KL; Grover PL; Phillips DH
    IARC Sci Publ; 1993; (124):233-42. PubMed ID: 8225490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
    Gupta RC; Earley K
    Carcinogenesis; 1988 Sep; 9(9):1687-93. PubMed ID: 3409474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution anion-exchange and partition thin-layer chromatography for complex mixtures of 32P-postlabeled DNA adducts.
    Spencer-Beach GG; Beach AC; Gupta RC
    J Chromatogr B Biomed Appl; 1996 Mar; 677(2):265-73. PubMed ID: 8704930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: application to unidentified genotoxicants.
    Randerath K; Miller RH; Mittal D; Randerath E
    IARC Sci Publ; 1988; (89):361-7. PubMed ID: 3198221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 32P-postlabelling of DNA adducts in styrene oxide-modified DNA and in workers exposed to styrene.
    Vodicka P; Hemminki K
    IARC Sci Publ; 1993; (127):109-18. PubMed ID: 8070856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 32P-postlabelling analysis of human tissues and its potential use for biomonitoring.
    Jones NJ; McGregor AD; Hoskins PL; Waters R
    IARC Sci Publ; 1993; (124):349-55. PubMed ID: 8225505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postlabelling HPLC analysis of lipophilic DNA adducts from human lung.
    Kari Hemminki Ke Yang Heli Rajaniemi Margarita Tyndyk Alexei Likhachev
    Biomarkers; 1997; 2(6):341-8. PubMed ID: 23889151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing of quantitative parameters in the 32P-postlabelling method.
    Hemminki K; Försti A; Löfgren M; Segerbäck D; Vaca C; Vodicka P
    IARC Sci Publ; 1993; (124):51-63. PubMed ID: 8225510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of DNA modifications by the 32P-postlabelling assay.
    Phillips DH
    Mutat Res; 1997 Aug; 378(1-2):1-12. PubMed ID: 9288880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of an interlaboratory trial of 32P-postlabelling.
    Phillips DH; Castegnaro M
    IARC Sci Publ; 1993; (124):35-49. PubMed ID: 8225506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization by 32P-postlabelling of 8-methoxypsoralen adducts.
    Gillardeaux O; Perin-Rousel O; Perin F
    IARC Sci Publ; 1993; (124):133-9. PubMed ID: 8225476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment.
    Gallagher JE; Jackson MA; George MH; Lewtas J; Robertson IG
    Cancer Lett; 1989 Apr; 45(1):7-12. PubMed ID: 2540901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 32P-postlabeling of DNA adducts arising from complex mixtures: HPLC versus TLC separation applied to adducts from petroleum products.
    Eriksson HL; Zeisig M; Ekström LG; Möller L
    Arch Toxicol; 2004 Mar; 78(3):174-81. PubMed ID: 14652713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking-related DNA adducts in human cervical biopsies.
    Phillips DH; Ni Shé M
    IARC Sci Publ; 1993; (124):327-30. PubMed ID: 8225502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recoveries of DNA adducts of polycyclic aromatic hydrocarbons in the 32P-postlabelling assay.
    Segerbäck D; Vodicka P
    Carcinogenesis; 1993 Dec; 14(12):2463-9. PubMed ID: 8269613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ³²P-postlabelling for the sensitive detection of DNA adducts.
    Jones NJ
    Methods Mol Biol; 2012; 817():183-206. PubMed ID: 22147574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoaffinity clean-up combined with 32P-postlabelling analysis of 1,N6-ethenoadenine and 3,N4-ethenocytosine in DNA.
    Guichard Y; Nair J; Barbin A; Bartsch H
    IARC Sci Publ; 1993; (124):263-9. PubMed ID: 8225494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of DNA adducts in human oral tissue: correlation of adduct levels with tobacco smoking and differential enhancement of adducts using the butanol extraction and nuclease P1 versions of 32P postlabeling.
    Jones NJ; McGregor AD; Waters R
    Cancer Res; 1993 Apr; 53(7):1522-8. PubMed ID: 8453617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.